long intergenic non-protein coding RNA 601Genealiases: []
Q-omics provides the consensus-scored LINC00601 profile across patient tissues and cancer cell-line models. LINC00601 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, LINC00601 is differentially expressed in 7, with the highest sampling consensus in HNSC. Additionally, LINC00601 RNA expression shows 14,314 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight STAD, HNSC, and GBM as cancer lineages where LINC00601 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00601 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00601 survival associations across molecular data types. LINC00601 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00601 RNA expression–survival associations across cancer types. High LINC00601 expression shows unfavorable associations in STAD, MESO, LUAD, ACC, UCEC and LGG. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify STAD as the clearest survival context for LINC00601 RNA expression.
This table summarizes LINC00601 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00601. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00601 shows lower tumor expression in BRCA and higher tumor expression in HNSC, BLCA, LUAD, LIHC and LUSC. The HNSC box plot shows higher LINC00601 RNA expression in tumor versus normal tissue (log2 FC = +0.296, t-test p < 0.001).
This table shows molecular features associated with LINC00601 in patient tissues and cancer cell lines. In patient samples, LINC00601 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
